Drug Profile
ABT 224
Alternative Names: ABT-224; AU 224Latest Information Update: 24 Jan 2013
Price :
$50
*
At a glance
- Originator Abbott Laboratories
- Class Gastrokinetics; Piperidines; Small molecules
- Mechanism of Action Cholinergic receptor agonists; Serotonin 4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Constipation
Most Recent Events
- 23 Sep 2003 Phase-II clinical trials in Constipation in USA (PO)
- 14 Jun 2002 Phase-I clinical trials in Constipation in Japan (unspecified route)